NEW YORK (Reuters Health) – Among patients undergoing cardiac procedures, a lower dose of contrast medium based on calculated creatinine clearance may reduce the risk of contrast-induced nephropathy,…
NEW YORK (Reuters Health) – Pegylated liposomal doxorubicin may be an alternative to paclitaxel in combination with carboplatin for advanced ovarian cancer, based on the results of an…
NEW YORK (Reuters Health) – Perioperative treatment with low-dose human atrial natriuretic peptide (carperitide) improves outcomes in patients with chronic kidney disease (CKD) who are undergoing coronary artery…
NEW YORK (Reuters Health) – An analysis of the sensitivity of several diagnostic tests for histoplasmosis indicates that combining antigen and antibody testing, as well as culture and…
NEW YORK (Reuters Health) – For best results, laparoscopic cholecystectomy in patients with acute cholecystitis should be performed within 48 hours of hospital admission, a Swiss team reports.…
NEW YORK (Reuters Health) – Combining an EGFR-directed tyrosine kinase inhibitor with conventional chemotherapy does not seem to be a good treatment strategy for lung cancer. According to…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…
NEW YORK (Reuters Health) – Algorithms based on procalcitonin (PCT) measurements reduce the use of antibiotics without jeopardizing patient safety, according to a review of randomized clinical trials.…
NEW YORK (Reuters Health) – Some patients with primary open-angle glaucoma benefit from more frequent visual field testing, according to results of a study published online August 8…
NEW YORK (Reuters Health) – Cardiac magnetic resonance (CMR) stress perfusion imaging for possible ischemia provides “robust” prognostic information regardless of patient sex, new research indicates. In the…
